Berenice Hatat
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effects of inter-individual variability in experimenters' sensitivity and training on behavioral assessment of animal models of vestibular disorders.
Journal: Frontiers in neurology
Published: November 22, 2024
Effect of Fluoxetine and Acacetin on Central Vestibular Compensation in an Animal Model of Unilateral Peripheral Vestibulopathy.
Journal: Biomedicines
Published: July 12, 2022
Vertigoheel improves central vestibular compensation after unilateral peripheral vestibulopathy in rats.
Journal: Frontiers in neurology
Published: June 14, 2022
Characterization of Thyroid Hormones Antivertigo Effects in a Rat Model of Excitotoxically-Induced Vestibulopathy.
Journal: Frontiers in neurology
Published: February 16, 2022
Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: August 24, 2020
Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer's Disease.
Journal: Molecules (Basel, Switzerland)
Published: July 18, 2019
Novel multi target-directed ligands targeting 5-HT4 receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: May 31, 2019
A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT4R) Agonist and Serotonergic Subtype 6 Receptor (5-HT6R) Inverse Agonist Activities, With a Potential Interest Against Alzheimer's Disease.
Journal: Frontiers in aging neuroscience
Published: April 11, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026